Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice.

Cancers (Basel) · 2021 · PMC8394018 · PMID 34439331

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

The memantine cotreatment had a nonsignificant trend in increasing the BrdU-immunopositive cell count when compared with that in the paclitaxel treatment group.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.